• About
    • About
    • Leadership
  • Science
    • Product
    • Pipeline
    • Publications
    • Clinical Trials
  • News
  • Careers
  • Contact
Restoring balance to the immune system
  • About
    • About
    • Leadership
  • Science
    • Product
    • Pipeline
    • Publications
    • Clinical Trials
  • News
  • Careers
  • Contact

Archives

Monthly Archive for: "May, 2020"
By PG
In News
Posted May 20, 2020

Sentien CEO Brian Miller Interviewed About Pursuing SBI-101 Treatment for COVID-19 Patients

Read More
By PG
In Press Releases
Posted May 15, 2020

Sentien Biotechnologies Names Richard Ganz as Executive Chairman

LEXINGTON, MA – Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced the appointment of Richard Ganz as Executive [...]

Read More
By PG
In News
Posted May 12, 2020

Sentien to Present SBI-101 Clinical Data in AKI at 2020 ASGCT Annual Meeting that Supports Expansion to COVID-19

Read More
Sentien Biotechnologies, Inc.
99 Hayden Avenue
Building E, Suite 140
Lexington, MA 02421

+1-781-361-9031
info@sentienbiotech.com
Connect With Us
Home About About Leadership Boards Science Product Pipeline Publications Clinical Trials
News Careers Contact
Copyright © Privacy Policy Terms of Use Site Design: Monderer Design